CAR T CELL THERAPY
Clinical trials for CAR T CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough leukemia in early trial
Disease control Not yet recruitingThis early-stage study tests a new type of CAR-T cell therapy (FO33 CAR-T) for people with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target the CD33 protein found on most AML…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
New CAR-T therapy made inside the body could cut costs for blood cancer patients
Disease control Not yet recruitingThis early-stage study tests a new type of CAR-T cell therapy that is made inside the body, avoiding the expensive and complex lab process normally needed. It targets two proteins (CD19 and BAFF-R) on cancer cells in people with relapsed or hard-to-treat B-cell acute leukemia or …
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
Can the RSV vaccine protect vulnerable cancer survivors?
Knowledge-focused Not yet recruitingThis study looks at whether the RSV vaccine (Abrysvo) can help people with blood cancers who have had a bone marrow transplant or CAR-T cell therapy build immunity against RSV. About 30 adults will get the vaccine, and researchers will measure their antibody levels before and aft…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: Knowledge-focused
Last updated May 17, 2026 05:33 UTC
-
Gene therapy patients to be tracked for 15 years in safety study
Knowledge-focused Not yet recruitingThis study follows up to 500 people who received gene therapy for CAR T-cell conditions. Researchers will check for delayed side effects and how long the therapy lasts in the body. No new treatment is given—just regular safety checkups for up to 15 years.
Matched conditions: CAR T CELL THERAPY
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Blood cancer Patients' daily struggles tracked in new hospital study
Knowledge-focused Not yet recruitingThis study follows 162 blood cancer patients during their hospital stay for either a stem cell transplant or CAR-T therapy. Researchers will use a simple questionnaire to measure how symptoms and quality of life change from admission to discharge. The goal is to understand which …
Matched conditions: CAR T CELL THERAPY
Sponsor: Associazione Qol-one • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
New study probes brain fog after cancer treatment
Knowledge-focused Not yet recruitingThis study looks at why some people develop confusion and memory problems after CAR-T therapy, a treatment for certain blood cancers. Researchers will follow 10 patients at high risk for these side effects, using brain scans and tests before, during, and after treatment. The goal…
Matched conditions: CAR T CELL THERAPY
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC